Broncholytin 40mg 20 tablets

Broncholytin Composition
active ingredient: glaucine hydrobromide;

1 coated tablet contains glaucine hydrobromide 40 mg;

excipients: wheat starch, sucrose, gelatin, microcrystalline cellulose, talc, stearic acid;

shell: gelatin, titanium dioxide (E 171), sucrose, acacia, talc, macrogol 6000, glycerin, for 10 mg: Opalux pink AS-24825 (sucrose, purified water, titanium dioxide (E 171), carmine (E 120), povidone (E 1201), Ponceau 4R (E 124), sodium benzoate (E 211), indigo carmine (E 132)) or for 40 mg: Opalux orange AS-23060 (sucrose, purified water, titanium dioxide (E 171), yellow sunset FCF (E 110), talc, iron oxide yellow (E 172), povidone (E 1201), sodium benzoate (E 211), indigo carmine (E 132)).

Pharmacotherapeutic group
Antitussives.

Indications
Symptomatic treatment of dry cough of various etiologies in infectious and inflammatory diseases of the upper respiratory tract, including acute and chronic bronchitis, influenza.

Dosage and administration
Method of application and dose.

Broncholytin Tab is administered orally, it is recommended to take the drug after meals.

Adults

A single dose for adults is 40 mg, applied 2-3 times a day. In more severe cases, a single dose can be increased to 80 mg. The maximum daily dose should not exceed 200 mg.

Children from 4 years old

A single dose for children from 4 years of age is 10 mg, taken 2-3 times a day.

The maximum daily dose should not exceed 40 mg.

Patients with impaired liver and kidney function

For patients with kidney and liver disease, it is necessary to reduce the dose of the drug or increase the interval between doses.

The duration of treatment with Broncholytin Tab should not exceed 5 days.

The use of the drug for a longer period and in higher doses is possible only as directed and under the constant supervision of a physician.